Hepatocarcinogenesis in FXR−/− Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression
- 1 May 2012
- journal article
- research article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 26 (5), 775-785
- https://doi.org/10.1210/me.2011-1383
Abstract
Farnesoid X receptor (FXR) (nuclear receptor subfamily 1, group H, member 4) is a member of nuclear hormone receptor superfamily, which plays essential roles in metabolism of bile acids, lipid, and glucose. We previously showed spontaneously hepatocarcinogenesis in aged FXR−/− mice, but its relevance to human hepatocellular carcinoma (HCC) is unclear. Here, we report a systematical analysis of hepatocarcinogenesis in FXR−/− mice and FXR expression in human liver cancer. In this study, liver tissues obtained from FXR−/− and wild-type mice at different ages were compared by microarray gene profiling, histological staining, chemical analysis, and quantitative real-time PCR. Primary hepatic stellate cells and primary hepatocytes isolated from FXR−/− and wild-type mice were also analyzed and compared. The results showed that the altered genes in FXR−/− livers were mainly related to metabolism, inflammation, and fibrosis, which suggest that hepatocarcinogenesis in FXR−/− mice recapitulated the progression of human liver cancer. Indeed, FXR expression in human HCC was down-regulated compared with normal liver tissues. Furthermore, the proinflammatory cytokines, which were up-regulated in human HCC microenvironment, decreased FXR expression by inhibiting the transactivity of hepatic nuclear factor 1α on FXR gene promoter. Our study thereby demonstrates that the down-regulation of FXR has an important role in human hepatocarcinogenesis and FXR−/− mice provide a unique animal model for HCC study.Keywords
This publication has 36 references indexed in Scilit:
- Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout MiceThe Journal of pharmacology and experimental therapeutics, 2011
- Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasisJCI Insight, 2011
- miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in miceHepatology, 2010
- FXR Regulates Liver Repair after CCl4-Induced Toxic InjuryMolecular Endocrinology, 2010
- Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcriptionHepatology, 2009
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008
- Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3The Journal of Experimental Medicine, 2007
- Spontaneous hepatocarcinogenesis in farnesoid X receptor-null miceCarcinogenesis: Integrative Cancer Research, 2006
- Benefit of farnesoid X receptor inhibition in obstructive cholestasisProceedings of the National Academy of Sciences of the United States of America, 2006
- Hepatocellular carcinomaJournal of Hepatology, 2000